A multifaceted pharmacist intervention to improve antihypertensive adherence: A cluster-randomized, controlled trial (HAPPy trial)

Abstract

What is known and objectives About half of all patients taking antihypertensives discontinue treatment by 12 months. There is potential for substantial health gains at both individual and population levels through improved treatment adherence. The objective was to evaluate a community pharmacist intervention to improve adherence with antihypertensive medicines with a view to improving blood pressure (BP) control. Methods Design: prospective, non-blinded, cluster-randomized, controlled trial. Participants: adults with primary hypertension who obtained antihypertensives in the previous 6 months. Patients with poor refill adherence were preferentially identified with the help of a purpose-built..